CME Group Inc.
CME Group Inc. (CME) Stock Overview
Explore CME Group Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
112B
P/E Ratio
27.89
EPS (TTM)
$11.16
ROE
0.14%
CME Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CME Group Inc. (CME) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $270.43.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.89 and a market capitalization of 112B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.